Champions Oncology sells products to personalize the development and use of oncology drugs in the United States, including the Tumorgraft Technology Platform. This platform provides personalized cancer care through the implantation of human tumors in immune-deficient mice, and offers Translational Oncology Solutions to assist with drug development. The company also provides Lumin Bioinformatics and markets its products through internet, word of mouth, and a sales force to patients and physicians.